Boston Scientific Non-GAAP EPS of $0.80 beats by $0.01, revenue of $5.2B beats by $30M [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
Reported net sales of $5.203 billion, representing an increase of 11.6 percent on a reported basis, compared to the company's guidance range of 10.5 to 12.0 percent; and 9.4 percent on an operational and organic basis, compared to the company's guidance range of 8.5 to 10.0 percent, all compared to the prior year period. MedSurg: 7.8 percent reported, 5.7 percent operational and organic Cardiovascular: 13.5 percent reported, 11.2 percent operational and organic Achieved the following net sales growth in each region, compared to the prior year period: United States U.S. ): 10.9 percent reported and operational Europe Middle East and Africa (EMEA): 10.1 percent reported and 1.2 percent operational Asia-Pacific APAC ): 14.7 percent reported and 12.0 percent operational Latin America and Canada (LACA): 19.0 percent reported and 12.0 percent operational The company now estimates net sales growth for the full year 2026, versus the prior year period, to be approximately 7.0 to
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales [Yahoo! Finance]Yahoo! Finance
- Boston Scientific (BSX) had its price target lowered by Barclays PLC from $124.00 to $100.00. They now have an "overweight" rating on the stock.MarketBeat
- Boston Scientific cuts 2026 profit forecast, trims revenue growth view [BNN Bloomberg (Canada)]BNN Bloomberg
- BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026Business Wire
- BSX Investor Alert: BOSTON SCIENTIFIC CORPORATION Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Electrophysiology Procedure Growth: Levi & KorsinskyPR Newswire
BSX
Earnings
- 4/22/26 - In-Line
BSX
Sec Filings
- 4/22/26 - Form 8-K
- 4/2/26 - Form EFFECT
- 4/1/26 - Form 424B3
- BSX's page on the SEC website